NGM

NGM Biopharmaceuticals, Inc. Common Stock

Delisted

NGM was delisted on the 4th of April, 2024.

122 hedge funds and large institutions have $200M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 44 increasing their positions, 44 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
122
Holders Change
-3
Holders Change %
-2.4%
% of All Funds
1.95%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
14
Increased
44
Reduced
44
Closed
17
Calls
$124K
Puts
$9K
Net Calls
+$115K
Net Calls Change
-$1.21M
Name Holding Trade Value Shares
Change
Shares
Change %
PVI
126
Pura Vida Investments
New York
-$417K -83,154 Closed
AQR Capital Management
127
AQR Capital Management
Connecticut
-$384K -76,477 Closed
FRM
128
Fox Run Management
Connecticut
-$230K -45,798 Closed
LCM
129
Landscape Capital Management
New Jersey
-$108K -21,492 Closed
AGM
130
Alpine Global Management
New York
-$89K -17,765 Closed
Franklin Resources
131
Franklin Resources
California
-$82.8K -16,500 Closed
Balyasny Asset Management
132
Balyasny Asset Management
Illinois
-$78.3K -15,600 Closed
DT
133
Diversified Trust
Tennessee
-$65K -12,885 Closed
YIH
134
Y-Intercept (HK)
Hong Kong
-$62.6K -12,475 Closed
Walleye Trading
135
Walleye Trading
New York
-$52.9K -10,528 Closed
WHG
136
Westwood Holdings Group
Texas
-$51K -10,235 Closed
Rockefeller Capital Management
137
Rockefeller Capital Management
New York
-$5K -1,000 Closed
MPWT
138
MassMutual Private Wealth & Trust
Connecticut
-$2K -334 Closed